Exelixis Inc. (EXEL) - Rasio kapitalisasi marang bathi resik

Simbol lan logo merek Exelixis Inc (EXEL)

Exelixis, Inc. (EXEL) maintains its production capacities and patents within the US, ensuring business reliability. The company's P/E fluctuations visualize the balance between value and earnings, where the 19.60 level captures the latest values. Robust protection for Cabometyx and consistent demand generate excess profits, while surplus liquidity enables efficient investment in new developments, sustaining high margins.

EXEL exelixis.com: Koefisien rega marang bathi ing interval 04.07.2022 - 12.11.2026

Rincian metrik komprehensif lan analitis Exelixis Corp (EXEL)

- rega pasar lan target rega analis:
Rega bursa exelixis.com|EXEL - Prakiraan konsensus analis
- indikator kapitalisasi pasar:
Kapitalisasi pasar Exelixis, Inc.|EXEL - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- data nilai buku modal saham:
Nilai Aset Bersih saben Saham Exelixis|EXEL - Aset Bersih Perusahaan|Nilai Pasar marang Nilai Buku exelixis.com|EXEL - Gunggung Aset Perusahaan
- statistik kawajiban utang lan likuiditas:
Utang Agregat marang Modal Exelixis, Inc.|EXEL - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Exelixis Inc.|EXEL - Utang perusahaan|Rasio utang marang aset resik Exelixis, Inc.|EXEL - Utang jangka dawa perusahaan|Tanggungan jangka cendhak Exelixis|Likuiditas darurat exelixis.com
- data bathi bisnis lan rasio investasi:
EXEL - Penghasilan resik|Bathi resik mangsa ngarep Exelixis, Inc.|EXEL - Pangali P/E|Rasio prakiraan rega marang bathi Exelixis Inc|EXEL - Pangali PEG|Nilai perusahaan marang bathi operasional sadurunge panyusutan Exelixis, Inc.|EXEL - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Exelixis|EXEL - Bathi resik saben saham sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan exelixis.com|EXEL - Wutah bathi ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Exelixis, Inc.
Analisis komprehensif perusahaan:exelixis.com - EXEL
Produk dadi Exelixis Corp

Assessing the market resilience of Exelixis, Inc. (EXEL) requires an analysis of the ratio between business value and net income. The integration of ESG standards into oncology development minimizes regulatory risks, thereby increasing the asset's fundamental value. The GURU.Markets toolkit visualizes the return on investment coefficient via the company's annual P/E, reflecting the current discounting of future earnings. Identifying local minimums for this indicator allows for the determination of the optimal entry point to maximize returns.

Pesaing wigati

Kapitalisasi marang bathi genmab.com GMAB|Pangali P/E NUVL|Kymera Therapeutics, Inc. (KYMR) - Rasio kapitalisasi marang bathi resik|IDEAYA Bio - Koefisien rega marang bathi|Enliven Corp (ELVN) - Kapitalisasi marang bathi|ORIC: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik RLAY (relaytx.com)|NRIX (Nurix Therapeutics, Inc.) - Koefisien rega marang bathi|TYRA: Rasio rega pasar marang bathi resik|VSTM (Verastem Inc) - Pangali P/E|Pangali P/E Monte Rosa Corp|Rasio rega marang bathi Cullinan Therapeutics (CGEM)|IMRX (immuneering.com) - Nilai perusahaan marang bathi resik|Pangali P/E CCCC (C4 Therapeutics)|Rasio kapitalisasi marang bathi resik Black Diamond Therapeutics, Inc.|Repare Rx - Pangali P/E|Kapitalisasi marang bathi PMV Pharmaceuticals, Inc|KPTI (karyopharm.com) - Koefisien rega marang bathi|PPCB: Rasio rega pasar marang bathi resik|BGMS (Bio Green Med Solution) - Pangali P/E|Kapitalisasi marang bathi Aadi Bio AADI|Pangali P/E ALRN|blueprintmedicines.com - Pangali rega marang bathi|GlycoMimetics - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik SWTX